z-logo
Premium
Association between single nucleotide polymorphisms of upstream transcription factor 1 ( USF 1 ) and susceptibility to papillary thyroid cancer
Author(s) -
Yuan Qingzhong,
Bu Qingao,
Li Guoqiang,
Zhang Jun,
Cui Tao,
Zhu Rui,
Mu Dongpo
Publication year - 2016
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.12832
Subject(s) - single nucleotide polymorphism , odds ratio , snp , medicine , oncology , snp genotyping , thyroid cancer , papillary thyroid cancer , confidence interval , allele , genotyping , biology , genetic association , genetics , genotype , cancer , gene
Summary Background Thyroid cancer, predominantly by papillary thyroid cancer ( PTC ), is a malignant tumour of endocrine system with increasing incidence rate worldwide. Upstream transcription factor 1 ( USF 1 ) regulates a variety of biological processes by transactivation of functional genes. In this study, we investigated the association between USF 1 polymorphisms and PTC risk. Material & Methods A total of 334 patients with PTC , 186 patients with benign nodules ( BN ) and 668 healthy controls were enrolled in our study. Tag‐ SNP s were identified in Chinese Han in Beijing ( CHB ) from International HapMap Project Databases. Genomic DNA s were extracted by TaqMan Blood DNA kits. SNP s of USF 1 were genotyped by TaqMan SNP s genotyping assay. Odds ratios ( OR ) and corresponding 95% confidence interval ( CI ) were used to assess the association between USF 1 genetic variants and PTC risk. The statistical analyses were carried out with spss 13.0 software. Results Five tag‐ SNP s were retrieved to capture all the genetic variants of USF 1 . Among the five tag‐ SNP s, genetic variants in rs2516838, rs3737787 and rs2516839 have significant association with PTC risk. The rs2516838 polymorphisms dominant model ( CG + GG vs CC : OR  = 0·71; 95% CI : 0·52–0·97; P  = 0·033) and allelic model (C vs G: OR  = 0·031; 95% CI : 0·56–0·97; P  = 0·031) indicated it may act as a protective factor against PTC . On the contrary, the results of rs3737787 polymorphisms: dominant model ( CT + TT vs CC : OR  = 1·55; 95% CI : 1·09–2·02; P  = 0·001) and allelic model (C vs T: OR  = 1·35; 95% CI : 1·10–1·64; P  = 0·003), as well as the results of rs2516839 polymorphisms: dominant model ( GA + AA vs GG : OR  = 1·77; 95% CI : 1·31–2·38; P  < 0·001) and allelic model (G vs A: OR  = 1·36; 95% CI : 1·13–1·63; P  = 0·014), revealed that they may act as risk factors for PTC . Conclusion In this study, we found the SNP s of rs2516838 (mutant G alleles vs wild C alleles), rs3737787 (mutant T alleles vs wild C alleles) and rs2516839 (mutant A alleles vs wild G alleles) were significantly associated with PTC risk. Further large‐scale studies with different ethnicities are still needed to validate our findings and explore the underlying mechanism of USF 1 in PTC development.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom